Norbert Krug, J. Hohlfeld, H. Geldmacher
Mar 1, 2005
Citations
0
Influential Citations
26
Citations
Quality indicators
Journal
Allergy
Abstract
Background: Loteprednol etabonate (LE) is a novel soft steroid that was designed to improve the benefit/risk ratio of topical corticosteroid therapy. This study assesses the clinical efficacy and safety of three different doses of LE nasal spray in seasonal allergic rhinitis (SAR).